Simulations & AI for small-molecule drug discovery
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,241
NCT03685084
Investigation of AAI101 Safety, Tolerability & PK in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 10, 2013
Completion: Jan 13, 2014
NCT03680378
Lung Pharmacokinetics (PK) in Epithelial Lining Fluid (ELF)
Start: Jul 1, 2017
Completion: Apr 30, 2019
NCT03680352
Pharmacokinetics of Cefepime and AAI101 in Subjects With Renal Insufficiency and Healthy Subjects
Start: Sep 1, 2017
Completion: Dec 30, 2018
NCT03680612
Cefepime/AAI101 Phase 2 Study in Hospitalized Adults With cUTI
Phase: Phase 2
Start: Sep 5, 2017
Completion: Feb 14, 2018
NCT03687255
Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections
Phase: Phase 3
Start: Sep 24, 2018
Completion: Feb 15, 2020
NCT03775668
Single Dose Mass Balance Study With C14 - Labeled AAI101 in Healthy Male Volunteers
Start: Nov 27, 2018
Completion: Jan 31, 2019
NCT05826990
A Study to Investigate PK, Safety, Tolerability of Cefepime-enmetazobactam in Pediatric Participants With cUTI
Start: Sep 11, 2023
Completion: Mar 30, 2026
Loading map...